Susquehanna International Group’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,096
| Closed | -$73.3K | – | 6364 |
|
|
2024
Q3 | $73.3K | Buy |
13,096
+11,722
| +853% | +$65.6K | ﹤0.01% | 5203 |
|
|
2024
Q2 | $18.4K | Buy |
+1,374
| New | +$18.4K | ﹤0.01% | 5408 |
|
|
2023
Q3 | – | Sell |
-1,213
| Closed | -$31.5K | – | 5797 |
|
|
2023
Q2 | $31.5K | Buy |
1,213
+800
| +194% | +$20.8K | ﹤0.01% | 5291 |
|
|
2023
Q1 | $10.4K | Sell |
413
-124
| -23% | -$3.13K | ﹤0.01% | 5717 |
|
|
2022
Q4 | $13.4K | Buy |
+537
| New | +$13.4K | ﹤0.01% | 5431 |
|
|
2022
Q3 | – | Sell |
-4,709
| Closed | -$153K | – | 6353 |
|
|
2022
Q2 | $153K | Buy |
4,709
+3,608
| +328% | +$117K | ﹤0.01% | 4756 |
|
|
2022
Q1 | $40K | Sell |
1,101
-1,743
| -61% | -$63.3K | ﹤0.01% | 5356 |
|
|
2021
Q4 | $152K | Sell |
2,844
-6,125
| -68% | -$327K | ﹤0.01% | 5115 |
|
|
2021
Q3 | $664K | Buy |
+8,969
| New | +$664K | ﹤0.01% | 3314 |
|
|
2021
Q2 | – | Sell |
-2,102
| Closed | -$1.8M | – | 5497 |
|
|
2021
Q1 | $1.8M | Buy |
+2,102
| New | +$1.8M | ﹤0.01% | 2246 |
|
|
2020
Q4 | – | Sell |
-180
| Closed | -$219K | – | 4899 |
|
|
2020
Q3 | $219K | Buy |
+180
| New | +$219K | ﹤0.01% | 3827 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4418 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4686 |
|
|
2019
Q4 | – | Sell |
-170
| Closed | -$42K | – | 4227 |
|
|
2019
Q3 | $42K | Buy |
170
+124
| +270% | +$30.6K | ﹤0.01% | 4222 |
|
|
2019
Q2 | $114K | Buy |
+46
| New | +$114K | ﹤0.01% | 4120 |
|
|
2019
Q1 | – | Sell |
-71
| Closed | -$220K | – | 3507 |
|
|
2018
Q4 | $220K | Buy |
+71
| New | +$220K | ﹤0.01% | 2854 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3755 |
|
|
2018
Q2 | – | Sell |
-38
| Closed | -$170K | – | 3945 |
|
|
2018
Q1 | $170K | Buy |
+38
| New | +$170K | ﹤0.01% | 2889 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 3915 |
|